Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Cancer. 2022 Feb 24;128(9):1863–1870. doi: 10.1002/cncr.34150

Table 3.

Univariate and multivariable predictors of event-free and overall survival among patients with B-ALL

Event-free Survival Overall Survival
Univariate Multivariable Univariate Multivariable
HR (95CI) P value HR (95CI) P value HR (95CI) P value HR (95CI) P value
Age at diagnosis (years)
 <10 Ref Ref Ref Ref Ref Ref Ref Ref
 ≥10 2.7 (2.4–2.9) <0.0001 1.7 (1.5–1.9) <0.0001 4.1 (3.6–4.8) <0.0001 2.5 (2.2–3.0) <0.0001
Sex
 Female Ref Ref Ref Ref Ref Ref Ref Ref
 Male 1.2 (1.1–1.3) 0.003 1.2 (1.1–1.3) 0.004 1.2 (1.0–1.3) 0.047 1.2 (1.0–1.4) 0.046
WBC at presentation (×109/L)
 <50 Ref Ref Ref Ref Ref Ref Ref Ref
 ≥50 2.1 (1.9–2.4) <0.0001 1.6 (1.4–1.8) <0.0001 2.3 (2.0–2.7) <0.0001 1.5 (1.3–1.8) <0.0001
CNS status
 CNS1 Ref Ref Ref Ref Ref Ref Ref Ref
 CNS2 1.8 (1.5–2.0) <0.001 1.4 (1.2–1.6) <0.0001 1.9 (1.6–2.3) <0.0001 1.4 (1.1–1.7) 0.002
 CNS3 1.7 (1.1–2.5) 0.008 0.9 (0.6–1.5) 0.82 2.2 (1.4–3.4) 0.0006 1.0 (0.6–1.8) 0.91
Cytogenetics
 Favorable Ref Ref Ref Ref Ref Ref Ref Ref
 Neutral 2.8 (2.5–3.3) <0.0001 2.1 (1.8–2.5) <0.0001 4.1 (3.3–5.1) <0.0001 2.9 (2.3–3.8) <0.0001
 Unfavorable 6.9 (5.7–8.2) <0.0001 3.6 (2.9–4.5) <0.0001 11.8 (9.3–15.2) <0.0001 5.8 (4.3–7.9) <0.0001
End of induction BM MRD
 <0.01% Ref Ref Ref Ref Ref Ref Ref Ref
 ≥0.01% 3.7 (3.3–4.1) <0.0001 2.9 (2.5–3.2) <0.0001 4.3 (3.7–5.0) <0.0001 2.9 (2.5–3.4) <0.0001

95CI – 95% confidence interval; BM – bone marrow; CNS – central nervous system; HR – hazard ratio; MRD – minimal residual disease; WBC – white blood cells